BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levin M, Barratt JM. Haemolytic uraemic syndrome. Arch Dis Child 1984;59:397-400. [PMID: 6375582 DOI: 10.1136/adc.59.5.397] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Powell HR, Davidson PM, Mccredie DA, Phair P, Walker RG. Haemolytic‐uraemic syndrome after treatment with metronidazole. Medical Journal of Australia 1988;149:222-3. [DOI: 10.5694/j.1326-5377.1988.tb120578.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
2 Lamont PM, Davidson AI. Haemolytic-uraemic syndrome presenting as an acute abdomen. Postgrad Med J 1987;63:807-9. [PMID: 3444808 DOI: 10.1136/pgmj.63.743.807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
3 Lindberg AA, Pál T. Strategies for development of potential candidate Shigella vaccines. Vaccine. 1993;11:168-179. [PMID: 8438615 DOI: 10.1016/0264-410x(93)90014-o] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Levin M, Walters M, Waterfield M, Stroobant P, Cheng D, Barratt T. PLATELET-DERIVED GROWTH FACTORS AS POSSIBLE MEDIATORS OF VASCULAR PROLIFERATION IN THE SPORADIC HAEMOLYTIC URAEMIC SYNDROME. The Lancet 1986;328:830-3. [DOI: 10.1016/s0140-6736(86)92868-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Milford DV, Taylor CM. New insights into the haemolytic uraemic syndromes. Arch Dis Child 1990;65:713-5. [PMID: 2201260 DOI: 10.1136/adc.65.7.713] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
6 Badami KG, Srivastava RN, Kumar R, Saraya AK. Disseminated intravascular coagulation in post-dysenteric haemolytic uraemic syndrome. Acta Paediatr Scand 1987;76:919-22. [PMID: 3425309 DOI: 10.1111/j.1651-2227.1987.tb17264.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
7 Beattie TJ. Recent developments in the pathogenesis of hemolytic uremic syndrome. Ren Fail 1990;12:3-7. [PMID: 2236721 DOI: 10.3109/08860229009066958] [Reference Citation Analysis]
8 Siegler RL. Management of hemolytic-uremic syndrome. The Journal of Pediatrics 1988;112:1014-20. [DOI: 10.1016/s0022-3476(88)80239-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
9 Abu-arafeh IA, Smail PJ, Youngson GG, Auchterlonie IA. Haemolytic uraemic syndrome in the defined population of Northeast of Scotland. Eur J Pediatr 1991;150:279-81. [DOI: 10.1007/bf01955532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Gleeson FV, Fitzpatrick MM, Somers J, Kennedy C, De Bruyn R, Barratt TM. Duplex Doppler ultrasound in the investigation of occult nephropathy following haemolytic uraemic syndrome. BJR 1992;65:137-9. [DOI: 10.1259/0007-1285-65-770-137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Long term renal outcome of childhood haemolytic uraemic syndrome. BMJ 1991;303:489-92. [PMID: 1912857 DOI: 10.1136/bmj.303.6801.489] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 1.9] [Reference Citation Analysis]
12 Green DA, Murphy WG, Uttley WS. Haemolytic uraemic syndrome: prognostic factors. Clin Lab Haematol 2000;22:11-4. [PMID: 10762298 DOI: 10.1046/j.1365-2257.2000.00272.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
13 Forsyth K, Fitzpatrick M, Simpson A, Barratt T, Levinsky R. NEUTROPHIL-MEDIATED ENDOTHELIAL INJURY IN HAEMOLYTIC URAEMIC SYNDROME. The Lancet 1989;334:411-4. [DOI: 10.1016/s0140-6736(89)90591-6] [Cited by in Crossref: 87] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
14 Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988;19:1102-8. [PMID: 3047052 DOI: 10.1016/s0046-8177(88)80093-5] [Cited by in Crossref: 230] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
15 Fizpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt TM. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. The Journal of Pediatrics 1993;122:532-7. [DOI: 10.1016/s0022-3476(05)83531-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
16 Mcgraw ME, Lendon M, Stevens RF, Postlethwaite RJ, Taylor CM. Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen. Pediatr Nephrol 1989;3:135-9. [DOI: 10.1007/bf00852894] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
17 Chart H, Cheasty T. Human infections with verocytotoxin-producing Escherichia coli O157--10 years of E. coli O157 serodiagnosis. J Med Microbiol 2008;57:1389-93. [PMID: 18927417 DOI: 10.1099/jmm.0.2008/003632-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
18 Elzouki AY, Mirza K, Mahmood A, Al-Sowailem AM. Hemolytic uremic syndrome - clinical aspects and outcome of an outbreak: Report of 28 cases. Ann Saudi Med 1995;15:113-6. [PMID: 17587918 DOI: 10.5144/0256-4947.1995.113] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Nammalwar BR, Balasubramanian N, Thangadurai C, Santhanakrishnan BR. Hemolytic uremic syndrome. Indian J Pediatr 1987;54:743-52. [PMID: 3323045 DOI: 10.1007/BF02751294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Karpman D, Håkansson A, Perez MR, Isaksson C, Carlemalm E, Caprioli A, Svanborg C. Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies. Infect Immun 1998;66:636-44. [DOI: 10.1128/iai.66.2.636-644.1998] [Cited by in Crossref: 132] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
21 Milford DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child 1990;65:716-21. [PMID: 2201261 DOI: 10.1136/adc.65.7.716] [Cited by in Crossref: 115] [Cited by in F6Publishing: 108] [Article Influence: 3.6] [Reference Citation Analysis]
22 Tönshoff B, Momper R, Kühl PG, Schweer H, Schärer K, Seyberth HW. Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney International 1990;37:1134-41. [DOI: 10.1038/ki.1990.96] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
23 Serebruany VL, Christenson MJ, Pescetti J, Mclean RH. Hypoproteinemia in the hemolytic-uremic syndrome of childhood. Pediatr Nephrol 1993;7:72-3. [DOI: 10.1007/bf00861576] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Kaplan BS, Cleary TG, Obrig TG. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol 1990;4:276-83. [DOI: 10.1007/bf00857676] [Cited by in Crossref: 83] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
25 Ruggenenti P, Remuzzi G. Thrombotic microangiopathies. Critical Reviews in Oncology/Hematology 1991;11:243-65. [DOI: 10.1016/1040-8428(91)90028-b] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Brandt ML, O'regan S, Rousseau E, Yazbeck S. Surgical complications of the hemolytic-uremic syndrome. Journal of Pediatric Surgery 1990;25:1109-12. [DOI: 10.1016/0022-3468(90)90741-q] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Ruggenenti P, Remuzzi G. Thrombotic Microangiopathy. In: Suki WN, Massry SG, editors. Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Boston: Springer US; 1997. pp. 513-27. [DOI: 10.1007/978-1-4757-6632-5_31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
28 Slavicek J, Puretić Z, Novak M, Sarnavka V, Benjak V, Glavas-Boras S, Thune S. The role of plasma exchange in the treatment of severe forms of hemolytic-uremic syndrome in childhood. Artif Organs 1995;19:506-10. [PMID: 8526789 DOI: 10.1111/j.1525-1594.1995.tb02370.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
29 Rose P, Clark A. Haematology of the haemolytic uraemic syndrome. Blood Reviews 1989;3:136-40. [DOI: 10.1016/0268-960x(89)90009-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Fitzpatrick MM, Dillon MJ. Current views on aetiology and management of haemolytic uraemic syndrome. Postgrad Med J 1991;67:707-9. [PMID: 1754520 DOI: 10.1136/pgmj.67.790.707] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Kavi J, Wise R. Causes of the haemolytic uraemic syndrome. BMJ 1989;298:65-6. [PMID: 2493295 DOI: 10.1136/bmj.298.6666.65] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
32 Situnayake RD, Crump BJ, Thurnham DI, Taylor CM. Further evidence of lipid peroxidation in post-enteropathic haemolytic-uraemic syndrome. Pediatr Nephrol 1991;5:387-92. [DOI: 10.1007/bf01453659] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Walters MD, Levin M, Smith C, Nokes TJ, Hardisty RM, Dillon MJ, Barratt TM. Intravascular platelet activation in the hemolytic uremic syndrome. Kidney International 1988;33:107-15. [DOI: 10.1038/ki.1988.17] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
34 Rose PE, Armour JA, Williams CE, Hill FG. Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome. J Clin Pathol 1985;38:438-41. [PMID: 2859303 DOI: 10.1136/jcp.38.4.438] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 1.0] [Reference Citation Analysis]
35 Taylor CM, Milford DV, White RH. A plea for standardized terminology within the haemolytic uraemic syndromes. Pediatr Nephrol 1991;5:97. [PMID: 2025550 DOI: 10.1007/BF00852859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 1992;42:951-6. [PMID: 1453586 DOI: 10.1038/ki.1992.372] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 3.0] [Reference Citation Analysis]
37 Menzel D, Levi M, Dooijewaard G, Peters M, ten Cate JW. Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood. Ann Hematol 1994;68:43-8. [DOI: 10.1007/bf01695919] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
38 Renaud C, Niaudet P, Gagnadoux MF, Broyer M, Habib R. Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age. Pediatr Nephrol 1995;9:24-9. [PMID: 7742216 DOI: 10.1007/BF00858960] [Cited by in Crossref: 29] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
39 Herbold NM, Clotilde LM, Anderson KM, Kase J, Hartman GL, Himathongkham S, Lin A, Lauzon CR. Clustering of clinical and environmental Escherichia coli O104 isolates using the DiversiLab™ repetitive sequence-based PCR system. Curr Microbiol 2015;70:436-40. [PMID: 25447271 DOI: 10.1007/s00284-014-0728-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Chart H, Scotland SM, Rowe B. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol 1989;27:285-90. [DOI: 10.1128/jcm.27.2.285-290.1989] [Cited by in Crossref: 75] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
41 Walters MDS, Matthei IU, Kay R, Dillon MJ, Barratt TM. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol 1989;3:130-4. [DOI: 10.1007/bf00852893] [Cited by in Crossref: 105] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
42 Taylor CM, White RH, Winterborn MH, Rowe B. Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) 1986;292:1513-6. [PMID: 3087499 DOI: 10.1136/bmj.292.6534.1513] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 2.0] [Reference Citation Analysis]
43 Fitzpatrick MM, Shah V, Filler G, Dillon MJ, Barratt TM. Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 1992;6:50-3. [PMID: 1536740 DOI: 10.1007/BF00856833] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]